A study by Jafarirad et al. found that taking 450 mg/day of pomegranate extract (standardized to contain 40% ellagic acid) for 12 weeks can reduced liver enzyme levels (ALT and AST), hepatokine levels (fetuin‐A and FGF‐21), and IL‐6 levels while increasing total antioxidant capacity in 44 patients with NAFLD (Jafarirad et al., 2023). Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.